BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

562 related articles for article (PubMed ID: 27679460)

  • 21. The switch from Gd-DTPA to Gd-DOTA is not associated with decrease of the T1 signal intensity of the pallidus and dentate in a pediatric population.
    Gulino P; Bianchi A; Diciotti S; Scionti A; Sali L; Papadopulos P; Mascalchi M
    Acta Radiol; 2021 Mar; 62(3):368-376. PubMed ID: 32529894
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Signal intensity at unenhanced T1-weighted magnetic resonance in the globus pallidus and dentate nucleus after serial administrations of a macrocyclic gadolinium-based contrast agent in children.
    Rossi Espagnet MC; Bernardi B; Pasquini L; Figà-Talamanca L; Tomà P; Napolitano A
    Pediatr Radiol; 2017 Sep; 47(10):1345-1352. PubMed ID: 28526896
    [TBL] [Abstract][Full Text] [Related]  

  • 23. High Signal Intensity in the Dentate Nucleus and Globus Pallidus on Unenhanced T1-Weighted MR Images: Comparison between Gadobutrol and Linear Gadolinium-Based Contrast Agents.
    Moser FG; Watterson CT; Weiss S; Austin M; Mirocha J; Prasad R; Wang J
    AJNR Am J Neuroradiol; 2018 Mar; 39(3):421-426. PubMed ID: 29419400
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Diffusion-weighted imaging of the dentate nucleus after repeated application of gadolinium-based contrast agents in multiple sclerosis.
    Eisele P; Szabo K; Ebert A; Radbruch A; Platten M; Schoenberg SO; Gass A
    Magn Reson Imaging; 2019 May; 58():1-5. PubMed ID: 30630068
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Lack of increased signal intensity in the dentate nucleus after repeated administration of a macrocyclic contrast agent in multiple sclerosis: An observational study.
    Eisele P; Alonso A; Szabo K; Ebert A; Ong M; Schoenberg SO; Gass A
    Medicine (Baltimore); 2016 Sep; 95(39):e4624. PubMed ID: 27684794
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Gadoterate Meglumine Administration in Multiple Sclerosis has no Effect on the Dentate Nucleus and the Globus Pallidus Signal Intensities.
    Hannoun S; Issa R; El Ayoubi NK; Haddad R; Baalbaki M; Yamout BI; Khoury SJ; Hourani R
    Acad Radiol; 2019 Oct; 26(10):e284-e291. PubMed ID: 30527456
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Linear Gadolinium-Based Contrast Agents Are Associated With Brain Gadolinium Retention in Healthy Rats.
    Robert P; Violas X; Grand S; Lehericy S; Idée JM; Ballet S; Corot C
    Invest Radiol; 2016 Feb; 51(2):73-82. PubMed ID: 26606549
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pediatric Patients Demonstrate Progressive T1-Weighted Hyperintensity in the Dentate Nucleus following Multiple Doses of Gadolinium-Based Contrast Agent.
    Roberts DR; Chatterjee AR; Yazdani M; Marebwa B; Brown T; Collins H; Bolles G; Jenrette JM; Nietert PJ; Zhu X
    AJNR Am J Neuroradiol; 2016 Dec; 37(12):2340-2347. PubMed ID: 27469211
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Progressive increase of T1 signal intensity of the dentate nucleus on unenhanced magnetic resonance images is associated with cumulative doses of intravenously administered gadodiamide in patients with normal renal function, suggesting dechelation.
    Errante Y; Cirimele V; Mallio CA; Di Lazzaro V; Zobel BB; Quattrocchi CC
    Invest Radiol; 2014 Oct; 49(10):685-90. PubMed ID: 24872007
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Linear gadolinium-based contrast agent (gadodiamide and gadopentetate dimeglumine)-induced high signal intensity on unenhanced T
    Ichikawa S; Omiya Y; Onishi H; Motosugi U
    J Magn Reson Imaging; 2019 Apr; 49(4):1046-1052. PubMed ID: 30307671
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Signal intensity change on unenhanced T1-weighted images in dentate nucleus following gadobenate dimeglumine in patients with and without previous multiple administrations of gadodiamide.
    Ramalho J; Semelka RC; AlObaidy M; Ramalho M; Nunes RH; Castillo M
    Eur Radiol; 2016 Nov; 26(11):4080-4088. PubMed ID: 26911888
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Different Impact of Gadopentetate and Gadobutrol on Inflammation-Promoted Retention and Toxicity of Gadolinium Within the Mouse Brain.
    Anderhalten L; Silva RV; Morr A; Wang S; Smorodchenko A; Saatz J; Traub H; Mueller S; Boehm-Sturm P; Rodriguez-Sillke Y; Kunkel D; Hahndorf J; Paul F; Taupitz M; Sack I; Infante-Duarte C
    Invest Radiol; 2022 Oct; 57(10):677-688. PubMed ID: 35467573
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Quantification and Assessment of the Chemical Form of Residual Gadolinium in the Brain After Repeated Administration of Gadolinium-Based Contrast Agents: Comparative Study in Rats.
    Frenzel T; Apte C; Jost G; Schöckel L; Lohrke J; Pietsch H
    Invest Radiol; 2017 Jul; 52(7):396-404. PubMed ID: 28125438
    [TBL] [Abstract][Full Text] [Related]  

  • 34. T1-Weighted Hypersignal in the Deep Cerebellar Nuclei After Repeated Administrations of Gadolinium-Based Contrast Agents in Healthy Rats: Difference Between Linear and Macrocyclic Agents.
    Robert P; Lehericy S; Grand S; Violas X; Fretellier N; Idée JM; Ballet S; Corot C
    Invest Radiol; 2015 Aug; 50(8):473-80. PubMed ID: 26107651
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Intraindividual comparison of T1 relaxation times after gadobutrol and Gd-DTPA administration for cardiac late enhancement imaging.
    Doeblin P; Schilling R; Wagner M; Luhur R; Huppertz A; Hamm B; Taupitz M; Durmus T
    Eur J Radiol; 2014 Apr; 83(4):660-4. PubMed ID: 24433640
    [TBL] [Abstract][Full Text] [Related]  

  • 36. In vivo dentate nucleus MRI relaxometry correlates with previous administration of Gadolinium-based contrast agents.
    Tedeschi E; Palma G; Canna A; Cocozza S; Russo C; Borrelli P; Lanzillo R; Angelini V; Postiglione E; Morra VB; Salvatore M; Brunetti A; Quarantelli M
    Eur Radiol; 2016 Dec; 26(12):4577-4584. PubMed ID: 26905870
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Gadolinium Retention, Brain T1 Hyperintensity, and Endogenous Metals: A Comparative Study of Macrocyclic Versus Linear Gadolinium Chelates in Renally Sensitized Rats.
    Rasschaert M; Emerit A; Fretellier N; Factor C; Robert P; Idée JM; Corot C
    Invest Radiol; 2018 Jun; 53(6):328-337. PubMed ID: 29329151
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Lack of T1 hyperintensity in the dentate nucleus after 15 administrations of a macrocyclic contrast agent in multiple sclerosis.
    Eisele P; Szabo K; Alonso A; Ong M; Platten M; Schoenberg SO; Gass A
    J Neurol Neurosurg Psychiatry; 2018 Mar; 89(3):324-326. PubMed ID: 28710325
    [No Abstract]   [Full Text] [Related]  

  • 39. No Signal Intensity Increase in the Dentate Nucleus on Unenhanced T1-weighted MR Images after More than 20 Serial Injections of Macrocyclic Gadolinium-based Contrast Agents.
    Radbruch A; Haase R; Kieslich PJ; Weberling LD; Kickingereder P; Wick W; Schlemmer HP; Bendszus M
    Radiology; 2017 Mar; 282(3):699-707. PubMed ID: 27925871
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of at Least 10 Serial Gadobutrol Administrations on Brain Signal Intensity Ratios on T1-Weighted MRI in Children: A Matched Case-Control Study.
    Ozturk K; Nascene D
    AJR Am J Roentgenol; 2021 Sep; 217(3):753-760. PubMed ID: 33112200
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 29.